131 related articles for article (PubMed ID: 28988685)
1. Socioeconomic disparities affect survival in malignant ovarian germ cell tumors in AYA population.
Bownes LV; Stafman LL; Maizlin II; Dellinger M; Gow KW; Goldin AB; Goldfarb M; Langer M; Raval MV; Doski JJ; Nuchtern JG; Vasudevan SA; Beierle EA
J Surg Res; 2018 Feb; 222():180-186.e3. PubMed ID: 28988685
[TBL] [Abstract][Full Text] [Related]
2. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).
Solheim O; Kærn J; Tropé CG; Rokkones E; Dahl AA; Nesland JM; Fosså SD
Gynecol Oncol; 2013 Nov; 131(2):330-5. PubMed ID: 24001518
[TBL] [Abstract][Full Text] [Related]
3. Malignant ovarian germ cell tumor - role of surgical staging and gonadal dysgenesis.
Lin KY; Bryant S; Miller DS; Kehoe SM; Richardson DL; Lea JS
Gynecol Oncol; 2014 Jul; 134(1):84-9. PubMed ID: 24836278
[TBL] [Abstract][Full Text] [Related]
4. Disparities in fertility-sparing surgery in adolescent and young women with stage I ovarian dysgerminoma.
Stafman LL; Maizlin II; Dellinger M; Gow KW; Goldfarb M; Nuchtern JG; Langer M; Vasudevan SA; Doski JJ; Goldin AB; Raval M; Beierle EA
J Surg Res; 2018 Apr; 224():38-43. PubMed ID: 29506849
[TBL] [Abstract][Full Text] [Related]
5. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases.
Xu W; Li Y
Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis].
Liu Y; Ren T; Feng FZ; Wan XR; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):40-4. PubMed ID: 22455692
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).
Solheim O; Gershenson DM; Tropé CG; Rokkones E; Sun CC; Weedon-Fekjaer H; Fosså SD
Eur J Cancer; 2014 Jul; 50(11):1942-50. PubMed ID: 24857045
[TBL] [Abstract][Full Text] [Related]
8. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract][Full Text] [Related]
9. Minimally Invasive Staging of Apparent Stage I Malignant Ovarian Germ Cell Tumors: Prevalence and Outcomes.
Nasioudis D; Minis E; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
J Minim Invasive Gynecol; 2019; 26(3):471-476. PubMed ID: 29890352
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Features, Prognostic Factors, Survival Trends, and Treatment of Malignant Ovarian Germ Cell Tumors: A SEER Database Analysis.
Guo H; Chen H; Wang W; Chen L
Oncol Res Treat; 2021; 44(4):145-153. PubMed ID: 33706324
[TBL] [Abstract][Full Text] [Related]
11. Fertility-preserving surgery for advanced stage ovarian germ cell tumors.
Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
Gynecol Oncol; 2017 Dec; 147(3):493-496. PubMed ID: 29021083
[TBL] [Abstract][Full Text] [Related]
12. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D
Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985
[TBL] [Abstract][Full Text] [Related]
13. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
14. MALIGNANT OVARIAN GERM CELL TUMORS AT A TERTIARY CARE SETTING IN PAKISTAN.
Hannan A; Malik MA; Fasih S; Badar F; Siddiqui N
J Ayub Med Coll Abbottabad; 2015; 27(3):624-7. PubMed ID: 26721024
[TBL] [Abstract][Full Text] [Related]
15. Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapy.
Nasioudis D; Ko EM; Haggerty AF; Cory L; Giuntoli RL; Burger RA; Morgan MA; Latif NA
Gynecol Oncol; 2020 Jun; 157(3):613-618. PubMed ID: 32359845
[TBL] [Abstract][Full Text] [Related]
16. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis.
Stokes W; Amini A; Maroni PD; Kessler ER; Stokes C; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
J Pediatr Urol; 2017 Aug; 13(4):386.e1-386.e7. PubMed ID: 28153774
[TBL] [Abstract][Full Text] [Related]
17. Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base.
Lerro CC; Robbins AS; Fedewa SA; Ward EM
Urol Oncol; 2014 Jan; 32(1):23.e15-21. PubMed ID: 23395701
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of malignant ovarian germ cell tumors with relapse or failed in primary therapy].
Yang JX; Wang HB; Shen K; Huang HF; Pan LY; Wu M
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):273-6. PubMed ID: 19570465
[TBL] [Abstract][Full Text] [Related]
19. Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era".
Solheim O; Tropé CG; Rokkones E; Kærn J; Paulsen T; Salvesen HB; Hagen B; Vereide AB; Fosså SD
Gynecol Oncol; 2015 Feb; 136(2):224-9. PubMed ID: 25511159
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
